Cargando…

ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA

AIM: To explore the anti-tumor effects of esophageal cancer-related gene 2 (ECRG2) in combination with cisplatin (DDP) in DDP-resistant esophageal cancer cells (EC9706/DDP). METHODS: A drug-resistant cell model was established, with EC9706/DDP cells being treated with ECRG2 and/or DDP. Cell viabilit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Xin-Fang, Xu, Lin-Ping, Song, Hai-Yan, Li, Shuai, Wu, Chen, Wang, Ju-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2017
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352920/ https://www.ncbi.nlm.nih.gov/pubmed/28348485 http://dx.doi.org/10.3748/wjg.v23.i10.1796

Ejemplares similares

Effect of ECRG2 in combination with cisplatin on the proliferation and apoptosis of EC9706 cells
por: SONG, HAI-YAN, et al.
Publicado: (2014)

Downregulation and DNA methylation of ECRG4 in gastric cancer
por: Deng, Peng, et al.
Publicado: (2018)

Exosomal microRNA-588 from M2 polarized macrophages contributes to cisplatin resistance of gastric cancer cells
por: Cui, Hai-Yan, et al.
Publicado: (2021)

Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
por: Liu, Rongfeng, et al.
Publicado: (2021)

Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901
por: Xie, Xiao-Que, et al.
Publicado: (2017)

Narrow line between benefit and harm: Additivity of hyperthermia to cisplatin cytotoxicity in different gastrointestinal cancer cells
por: Cesna, Vaidotas, et al.
Publicado: (2018)

Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer
por: Van Der Steen, Nele, et al.
Publicado: (2016)

Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
por: Xiao, Jing-Bo, et al.
Publicado: (2020)

A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma
por: Li, Lin-wei, et al.
Publicado: (2011)

Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1
por: Tan, Xiangyu, et al.
Publicado: (2023)

Circular RNA AKT3 governs malignant behaviors of esophageal cancer cells by sponging miR-17-5p
por: Zang, Hong-Liang, et al.
Publicado: (2021)

The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
por: Li, Linwei, et al.
Publicado: (2010)

Deltonin enhances gastric carcinoma cell apoptosis and chemosensitivity to cisplatin via inhibiting PI3K/AKT/mTOR and MAPK signaling
por: Yang, Lin, et al.
Publicado: (2023)

Upregulation of Acetylcholinesterase Mediated by p53 Contributes to Cisplatin-Induced Apoptosis in Human Breast Cancer Cell
por: Ye, Xiaolei, et al.
Publicado: (2015)

Effects of paclitaxel and cisplatin on in vitro ovarian follicle development
por: Kim, Yoon Young, et al.
Publicado: (2019)

ECRG2, a novel transcriptional target of p53, modulates cancer cell sensitivity to DNA damage
por: Patel, Harsh, et al.
Publicado: (2020)

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
por: Wang, Bingliang, et al.
Publicado: (2015)

Retraction: The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma
por: Li, Linwei, et al.
Publicado: (2011)

Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer
por: Zhu, Han-Zhang, et al.
Publicado: (2020)

Berberine displays antitumor activity in esophageal cancer cells in vitro
por: Jiang, Shu-Xian, et al.
Publicado: (2017)

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients
por: Warnecke-Eberz, Ute, et al.
Publicado: (2020)

Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53
por: Li, Zhanjun, et al.
Publicado: (2014)

Reduced microRNA 375 in colorectal cancer upregulates metadherin-mediated signaling
por: Han, Seol-Hee, et al.
Publicado: (2019)

Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Di, Yuzhu, et al.
Publicado: (2021)

Downregulation of long non-coding RNA B-Raf proto-oncogene-activated non-coding RNA reverses cisplatin resistance in laryngeal squamous cell carcinoma
por: Han, Weiwei, et al.
Publicado: (2019)

Esophageal magnetic compression anastomosis in dogs
por: Xu, Xiang-Hua, et al.
Publicado: (2022)

Transcriptional factor III A promotes colorectal cancer progression by upregulating cystatin A
por: Wang, Jing, et al.
Publicado: (2022)

Magnetic anchor technique assisted endoscopic submucosal dissection for early esophageal cancer
por: Pan, Min, et al.
Publicado: (2023)

MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation
por: Zhang, Zhen, et al.
Publicado: (2019)

Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
por: Liao, Xiaozhong, et al.
Publicado: (2020)

Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin
por: Di, Yuzhu, et al.
Publicado: (2021)

RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes
por: Zeng, Rui‐Jie, et al.
Publicado: (2019)

Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
por: Koizumi, W, et al.
Publicado: (2013)

Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
por: Peng, Shuai, et al.
Publicado: (2021)

MicroRNA-320a suppresses tumor progression by targeting PBX3 in gastric cancer and is downregulated by DNA methylation
por: Li, Yong-Shuang, et al.
Publicado: (2019)

Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells
por: Rossi, Ana Flávia Teixeira, et al.
Publicado: (2022)

Long noncoding RNA TNFRSF10A-AS1 promotes colorectal cancer through upregulation of HuR
por: Wang, Dan-Dan, et al.
Publicado: (2022)

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to Cisplatin
por: Yang, Fan, et al.
Publicado: (2015)

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
por: Michel, P, et al.
Publicado: (2006)

Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis via NOTCH signaling pathway
por: Piao, Hai-Yan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ggr6cv5j4l3ebvjsdidik9tvnn